Sanofi To Invest US$75 million Into Vietnam Manufacturing Facility

Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in Ho Chi Minh City.

AsianScientist (Apr. 1, 2013) – Sanofi announced on Friday the official launch of a construction project for a new manufacturing facility in the Saigon High Tech Park – Ho Chi Minh City. The new state-of-the-art plant will expand Sanofi’s manufacturing capacity in Vietnam to meet the fast growing demand of the Vietnamese pharmaceutical market and will serve as an export platform to Southeast Asian countries.

The investment in this new plant will amount to US$75 million and will constitute Sanofi’s largest investment in Vietnam to date. With an initial capacity of 90 million units per year – and a possible extension up to 150 million units – the facility will produce high-quality pharmaceuticals and consumer healthcare products.

“This new production and development center is the largest investment ever made by Sanofi in Vietnam and illustrates our commitment to bringing high quality medicines to a broader population in Vietnam,” said Christopher A. Viehbacher, Chief Executive Officer of Sanofi, during the launch ceremony.

“Sanofi has been present in Vietnam for more than 50 years and has built the number 1 position in one of the most dynamic South East Asian countries. This new investment will contribute to further strengthen Sanofi’s leadership position in Emerging Markets.”

The plant is scheduled to be fully operational by the end of 2015 and will join Sanofi’s existing network of 40 manufacturing sites in Emerging Markets.

——

Source: Sanofi.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist